Literature DB >> 15017104

Diquafosol elicits increases in net Cl- transport through P2Y2 receptor stimulation in rabbit conjunctiva.

Tadahiro Murakami1, Tsutomu Fujihara, Yoshihide Horibe, Masatsugu Nakamura.   

Abstract

The purpose of the present study was to understand the mechanisms of action of diquafosol, a stable derivative of uridine 5'-triphosphate, on Cl(-) transport across the isolated rabbit conjunctiva. Rabbit conjunctivas were isolated and mounted in a modified Ussing chamber. Under short-circuit conditions, the effects were determined of mucosal (tear) side diquafosol application on the short-circuit current (Isc). Diquafosol rapidly and dose-dependently increased the Isc at concentrations ranging from 0.1 to 968 microM when added to the mucosal side of the conjunctiva. In the absence of the serosal Cl(-), the Isc induced by 10 microM diquafosol was substantially reduced. On the contrary, in the absence of mucosal side Na(+), the diquafosol-induced increases in Isc were unchanged. Following 45-min preincubation, the P2Y(2) antagonist suramin inhibited the diquafosol-induced increases in the Isc whereas the P2Y(1) antagonist pyridoxal-phosphate-6-azophenyl-2'4'-disulfonic acid had no effect. These studies suggest that diquafosol stimulates net Cl(-) secretion from the serosal to the mucosal side via stimulation of P2Y(2) receptors in the rabbit conjunctiva. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017104     DOI: 10.1159/000076887

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  29 in total

1.  Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.

Authors:  Chika Shigeyasu; Masakazu Yamada; Yoko Akune; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2015-08-27       Impact factor: 2.447

2.  The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.

Authors:  N Yokoi; H Kato; S Kinoshita
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

3.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

4.  Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.

Authors:  Lian Cui; Ying Li; Hyo Seok Lee; Jee Myung Yang; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-08-18       Impact factor: 2.031

5.  Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome.

Authors:  Dong-Hyun Kang; Yong-Woo Lee; Kyu-Yeon Hwang; Kyung-Min Koh; Young-A Kwon; Byung-Yeop Kim; Sang-Wroul Song; Kook-Young Kim
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

6.  Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome.

Authors:  Sang Wook Jin; Ji Sang Min
Journal:  Jpn J Ophthalmol       Date:  2016-02-12       Impact factor: 2.447

7.  Topical administration of ambroxol eye drops augments tear secretion in rabbits.

Authors:  Li Yu; Dhruva Bhattacharya; Zhenhan Wang; Mingwu Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-29       Impact factor: 3.117

8.  Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.

Authors:  K Kamiya; M Nakanishi; R Ishii; H Kobashi; A Igarashi; N Sato; K Shimizu
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

Review 9.  Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

10.  Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency.

Authors:  William R Thelin; M Ross Johnson; Andrew J Hirsh; Claire L Kublin; Driss Zoukhri
Journal:  J Ocul Pharmacol Ther       Date:  2012-03-28       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.